Cera Targets FY27 Margin as Discounts Ease Gradually

Cera Sanitaryware Limited — Q4 & FY26 Earnings Call (May 09, 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly frames the quarter as “improved performance” and “early signs of recovery” building into “confidence that demand conditions are gradually improving.”
• They provide clear FY27 growth and margin targets and discuss capacity expansion and brand scaling with confidence, despite acknowledging margin pressure.

2. Key Themes from Management Commentary

• Demand recovery gaining traction
• Q4 revenue grew 11.4% YoY, described as “gradual improvement” since Q3.
• Recovery seen across urban + select Tier 2/Tier 3 regions.
• Pricing actions to offset input cost volatility
• “Calibrated price revision” effective March 1: 4% sanitaryware and 11% faucetware.
• Management expects “continued volatility in key input prices” (metals/energy).
• Margin pressure persists, mainly from costs + discounts
• EBITDA margin 15.2% vs 18.3% YoY; attributed to:
  • “elevated brass input costs”
  • “continued trade discounts”
  • plus “pre-operating expenses” for Senator/Polipluz
• They expect progressive discount control as conditions stabilize.
• Brand architecture scaling (Senator + Polipluz) in investment phase
• Senator: 40 flagship stores operational, targeting 60 by FY27.
• Polipluz: 102 distributors / 1,120 dealers, targeting 200 / 2,000 by end-FY27.
• Management says outcomes are “expected to play out progressively.”
• Supply-side resilience vs Morbi disruptions
• Gas availability issues in Morbi; Cera is “relatively insulated” via gas sourcing (incl. GAIL at subsidized rates) and inventory/manufacturing capability.
• They are internalizing some sanitaryware categories to improve supply reliability.
• Capacity expansion with minimal capex
• Faucetware capacity expansion to 5 lakh pieces/month with “minimal capex ~INR 5 crore,” operational from Q4 FY27 onwards.

3. Q&A Analysis

Theme A: FY27 demand outlook (retail vs project mix)

• Core questions
• How retail demand will grow after being muted; expected retail vs institution/project balance.
• Management response
• Retail recovery started from Q3 FY26, sustained into Q4 and “surge in April.”
• Project share expected to stabilize: retail/project at 60%/40%.
• Volume guidance: faucetware 10–12%, sanitaryware 7–8% for FY27.
• Notable points / evasiveness
• They are confident retail recovery “should continue,” but provide limited evidence beyond April/Q4 trends.

Theme B: Pricing strategy, input cost pass-through, and margin bridge

• Core questions
• Challenges in taking price hikes; how much more pricing is needed; whether pricing covers brass/clay/gas cost increases.
• How to maintain ~14% EBITDA margin guidance.
• Management response
• Brass price moved from ~600–700 to 800–850; YoY brass cost increase ~29–30%.
• They cite cumulative retail price actions over ~2 months: 12% sanitaryware / 16% faucetware.
• Projects: price stable for booked orders (1-year norm).
• They claim a small residual brass gap (about 1–2%) to be “calibrated by discount controls.”
• Notable points / evasiveness
• “Discount management” is used as the lever, but there’s no quantified discount reduction plan.

Theme C: Margin outlook and discount persistence

• Core questions
• Why trade discounts continue despite demand recovery; whether margins can sustain.
• Management response
• Discounts are a “gradual journey,” not immediately controllable.
• They highlight Q4 margin uplift from 10.2% (Q3) to 15.2% (Q4).
• If demand trend continues, EBITDA margins expected around 14–15%.
• Notable points / evasiveness
• They acknowledge discounts as a key driver but do not specify a timeline/quant target for discount normalization.

Theme D: Operational continuity, Morbi exposure, inventory, and capacity utilization

• Core questions
• Capacity utilization in March/April; any disruption in June quarter.
• Outsourcing exposure to Morbi; finished goods inventory; tiles impact.
• Management response
• Sanitaryware utilization 70% in March; faucetware 106%.
• They closed one kiln temporarily due to gas visibility; expect utilization to improve to 70–75%.
• Outsourcing: sanitaryware 60% (Q4), faucetware 46% (Q4).
• Finished goods inventory: INR 303 crore (March), ~INR 300 crore (April).
• Tiles: expected impact in Q1/Q2 if outsourcing supply is constrained.
• Notable points / evasiveness
• They say Morbi sourcing in Q1 may be “sketchy” but rely on inventory and internalization; still, tiles risk is explicitly admitted.

Theme E: Brand economics (Senator/Polipluz) and revenue targets

• Core questions
• Revenue contribution from Senator/Polipluz in FY26; FY27 targets; breakeven and losses.
• Launch/marketing expenses and path to EBITDA targets for these brands.
• Management response
• FY26 revenue: Senator ~INR 10.5 cr, Polipluz ~INR 8.5 cr; total ~INR 19 cr.
• FY27 projection: Senator INR 40–45 cr, Polipluz INR 30–35 cr; total INR 70–80 cr.
• Losses: current quarter had “small loss” excluding publicity; with publicity, profits expected later.
• Senator expenses: FY26 Senator/Polipluz losses ~INR 7 cr / 1.5 cr; next year publicity INR 10–12 cr.
• Notable points / evasiveness
• They discuss breakeven qualitatively, but EBITDA targets for the portfolio are not fully reconciled with expense phasing.

Theme F: Employee cost, capex, and cash deployment

• Core questions
• Why employee cost down QoQ; FY27 capex; usage of cash.
• Management response
• Employee cost down due to wage code-related provisioning and a write-back (~INR 10 cr exceptional item) in Q4.
• FY27 capex guided around INR 45 cr (includes routine + faucet expansion + office space acquisition).
• Cash deployment: dividend payout increased; greenfield timing depends on demand; greenfield cost estimate ~INR 150 cr (after land already purchased INR 27 cr).
• Notable points / evasiveness
• Greenfield timing remains conditional; no firm start date.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 revenue growth (overall): ~18% to 20%
• FY27 volume growth
• Faucetware: 10% to 12%
• Sanitaryware: 7% to 8%
• FY27 segment revenue growth
• Sanitaryware revenue: ~12% (volume 7% + price 5–6%)
• Faucetware revenue: ~18% (volume 10–12% + price ~8%)
• FY27 EBITDA margin: expected to sustain ~14% to 15%
• Senator + Polipluz revenue targets (FY27):
• Senator INR 40–45 cr
• Polipluz INR 30–35 cr
• Combined INR 70–80 cr
• Capacity expansion
• Faucetware capacity to 5 lakh pieces/month from Q4 FY27 onwards
• Capex for expansion: ~INR 5 cr
• FY27 capex: ~INR 45 cr (incl. routine ~25 cr, faucet expansion ~5 cr, office space acquisition ~15 cr)
• Dividend: declared INR 75 per share (cash deployment signal)

Implicit signals (qualitative)

• Discount normalization expected as demand stabilizes (“progressively regain better control over discounts”).
• Morbi/gas disruption risk is being actively mitigated via internalization and inventory; however tiles may face Q1/Q2 impact.
• Greenfield is not committed; start depends on demand visibility (“right time… will be seen in coming quarters”).

5. Standout Statements (direct / high-signal)

• Demand recovery confidence: “demand conditions are gradually improving” and “reinforces our confidence.”
• Margin pressure explanation: margins below normal due to “higher input costs… and continued trade discounts.”
• Pricing actions: “calibrated price revision… effective from March 1st” (4% sanitaryware, 11% faucetware).
• Discount lever: “couple of percentage points… should be made up by way of better discount management.”
• FY27 growth call: “overall growth of around 18% to 20% next year.”
• Margin sustainability: “sustain the EBITDA margins at around 14% to 15%.”
• Morbi insulation: “Cera has remained relatively insulated from these disruptions.”
• Tiles risk admitted: “Tiles will be impacted… we expect that during Q1 will be impacted.”
• Brand scaling targets: Senator stores “targeting to scale… to 60 stores by next financial year”; Polipluz dealers “target… 2,000 by end of FY27.”
• Greenfield conditionality: “right time to start construction… will be seen in the coming quarters.”

6. Red Flags / Positive Signals

Red flags
– Margin guidance depends on discount control (a lever management admits is “gradual” and historically volatile).
– Tiles supply risk explicitly flagged for Q1/Q2 due to outsourcing dependence.
– Greenfield timing remains uncertain despite large cash balance and prior land purchase.
– Brand investment phase continues; profitability timing is still conditional (“small loss… publicity… profits… next year”).

Positive signals
– Clear FY27 growth + margin targets with segment-level volume/price decomposition.
– Capacity expansion with low capex suggests operational confidence.
– Working capital improvement: inventory days down (79 → 71), receivables down (37 → 33) in Q4.
– Supply resilience narrative is supported by gas sourcing and internalization actions.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current (Q4 FY26): More Optimistic
• Moves from “cautiously optimistic” / “green shoots” (Q2 FY26, Q1 FY26) to “confidence” and quantified FY27 growth/margin guidance.
• What changed
• Stronger demand evidence: April surge + sustained Q4 recovery.
• More willingness to quantify: FY27 18–20% growth and 14–15% EBITDA.
• Less emphasis on “uncertain timing”; more on execution and scaling.

b. Tracking Past Commitments vs Outcomes

• Senator/Polipluz revenue ramp
• Past (Q2 FY26, Nov 2025): expected to end FY26 at INR 40–45 cr combined (Senator+Polipluz).
• Current (Q4 FY26): FY26 combined revenue ~INR 19 cr.
• Flag: ❌ Missed / Dropped (materially lower than earlier expectation).
• Margin normalization narrative
• Past (Q3 FY26, Feb 2026): management framed Q3 margin drop as phasing/one-off and expected return to 13–14%.
• Current: Q4 EBITDA margin 15.2% (improved vs Q3), but still below “normal range” and guided FY27 14–15%.
• Flag: ✅ Partially delivered (directionally improved, but not fully back to prior “normal” consistently).
• Greenfield sanitaryware
• Past (Q1 FY26, Aug 2025): land purchased; construction deferred pending market view.
• Current (Q4 FY26): land purchased; construction start still conditional; cost estimate now ~INR 150 cr.
• Flag: ⏳ Delayed (still not started; uncertainty persists).

c. Narrative Shifts

• From “retail muted” to “retail recovery sustaining”
• Earlier calls emphasized retail softness and relied on project mix to balance.
• Now they assert retail recovery is continuing and project share should stabilize at 40%.
• Discounts as a persistent structural issue
• Earlier: discounts were “stabilizing” and price increases were limited by market.
• Now: discounts are still “continued” and are the main reason margins remain below normal.
• Supply chain strategy becomes more explicit
• Earlier: dealer management system, brand segmentation.
• Now: internalization due to Morbi gas disruptions and explicit outsourcing exposure.

d. Consistency & Credibility Signals

• Medium credibility
• Strength: management provides detailed cost/price mechanics and quantified FY27 targets.
• Weakness: brand revenue expectations were previously higher (Senator/Polipluz FY26 target) and were not met; greenfield remains repeatedly deferred.
• Margin explanations are consistent (brass + discounts + phasing), but the ability to control discounts is still the key uncertainty.

e. Evolution of Key Themes

• Demand: Improving (from “sluggish/uneven” to “gradual improvement” with April surge).
• Margins: Deteriorated in Q4 FY26 vs Q4 FY25, with partial recovery from Q3; still not back to “normal range.”
• Expansion: Faucetware capacity expansion now concrete; greenfield still conditional.
• Brand strategy: Senator/Polipluz remain investment-heavy; revenue contribution ramp is slower than earlier guidance.

f. Additional Insights (cross-period intelligence)

• Brand economics are taking longer to monetize than earlier investor-facing targets suggested (FY26 combined ~INR 19 cr vs earlier ~INR 40–45 cr expectation).
• Morbi/gas disruption is shifting from “macro risk” to “operational planning input” (kiln closures, internalization drive, tiles impact).
• Discount management is becoming the central “control knob” for margins—yet it’s also the least controllable variable (management calls it gradual).